Carnegie All Cap believes Coloplast presents a compelling turnaround opportunity.
Kavaljer finds that Bahnhof, despite being a historically fantastic contributor to fund returns, now faces significant headwinds that justify exiting the position.
Elementa believes that RaySearch Laboratories has delivered a transformational Q1 2025 performance, signaling...
Lannebo Teknik Småbolag believes cBrain offers a compelling investment opportunity due to...
Richard Bråse argues that Hufvudstaden has a unique opportunity that no other Swedish real estate company can seize: meaningful share buybacks from
Lancelot Fonder believes that Embracer Group represents a compelling special situation investment despite...
Magnus see a special situation value unlock opportunity as Lindex Group approaches...
Despite strong fundamentals and proven societal value, the market underappreciates Dynavox’s growth potential...
Kavaljer believes that Catella represents a classic sum-of-the-parts opportunity where...
Protean believes Acast is experiencing a transformational shift in its North American operations, with...
Arjo is a Swedish medical technology company that provides products and solutions to improve mobility and care for people with reduced mobility and age-related conditions.